Abdominal aortic aneurysm in normotensive patients: association with angiotensin-converting enzyme gene polymorphism

Eur J Vasc Endovasc Surg. 2001 May;21(5):445-9. doi: 10.1053/ejvs.2001.1339.

Abstract

Objective and design: to assess if deletion of the angiotensin-converting enzyme (ACE) gene is a risk factor for abdominal aortic aneurysms (AAAs) in normotensive patients.

Materials and methods: ACE gene polymorphism was examined by polymerase chain reaction in 124 subjects with AAA and in 112 control subjects. AAA normotensive patients (group A, n=56) were compared to normotensive control subjects (group B, n =112) and to AAA hypertensive patients (group C, n =68). All subjects enrolled in this study were Caucasian and from central and southern Italy.

Results: the distribution of ACE genotypes was: normotensive patients with AAAs (group A): 3 II, 14 ID, 39 DD; normotensive control subjects (group B): 36 II, 48 ID, 28 DD; hypertensive patients with AAAs (group C): 14 II, 32 ID, 22 DD. The DD genotype was more common in group A than in control groups (A vs B p<0.001; A vs C p <0.001). The ID genotype was more common in group A as well (A vs B p <0.05; A vs C p <0.005).

Conclusions: our data suggest a role for ACE I/D gene polymorphism in the pathogenesis of AAA in normotensive patients.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aortic Aneurysm, Abdominal / genetics*
  • Female
  • Humans
  • Hypertension / complications
  • Male
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Genetic

Substances

  • Peptidyl-Dipeptidase A